Latest Financial Position News

Deep Yellow Limited has accelerated development at its flagship Tumas uranium project in Namibia, nearing construction readiness with significant engineering and earthworks milestones. Exploration success at the nearby Tinkas Prospect and strategic leadership appointments position the company well amid a strengthening uranium market.

ECS Botanics reports a third straight quarter of positive operating cash flow, driven by strong B2C growth and strategic international shipments to Germany and New Zealand.

Elevate Uranium Ltd pushes back its U-pgradeTM pilot plant results to August 2026 amid operational tweaks, while reporting a doubled resource grade at Marenica and a 76.2 Mlb uranium resource at Koppies.

Black Canyon Limited has delivered robust metallurgical results confirming high-quality direct shipping ore (DSO) potential for manganese and iron at its Wandanya Project, alongside commencing a major 15,000m drilling campaign to define and expand resources.

Bio-Gene Technology is progressing critical toxicology studies for Flavocide with a targeted APVMA submission in March 2027, while forging a strategic partnership to launch Qcide insecticides in Japan by late 2026.

FINEOS Corporation Holdings PLC reported its strongest quarterly cash inflow ever alongside key contract wins in Australia and North America, maintaining its FY26 revenue guidance and advancing AI integration in its insurance software platform.

Kuniko Limited has launched a prospectus offering over 51 million new options following a $3.75 million share placement, aiming to facilitate secondary trading and potential future capital raising through option exercises.

Paradigm Biopharmaceuticals has upsized a $14 million placement and launched a $2 million SPP, boosting its cash runway to around $45 million. This capital injection supports the ongoing Phase 3 trial for knee osteoarthritis, with interim results expected in Q3 2026.

Flynn Gold has reported standout assay results from its Tasmanian projects, including exceptional silver-lead-zinc grades at Silver King and significant tungsten-gold mineralisation at Firetower and Warrentinna, underpinning a ramp-up in drilling and regional exploration.

Island Pharmaceuticals has cleared a major regulatory hurdle with the US FDA, confirming a clinical development path for its antiviral Galidesivir under the Animal Rule. Backed by a $9 million capital raise and strategic partnerships, the company is poised for potential US government procurement and biodefence market entry.

Marvel Gold has completed an extensive drone magnetic survey at its Hanang Gold Project in Tanzania, revealing new mineralisation corridors and preparing to launch its first drilling campaign. Meanwhile, the company is exiting Mali due to regulatory hurdles, progressing the sale of its Yanfolila project.

Albright Metals delivers strong high-grade gold results from its Golden Pike Project in Canada while boosting its balance sheet through a $1.8 million tenement sale to Catalyst Metals, sharpening its focus on high-impact assets.